Tvardi Therapeutics Inc (TVRD)
SG&A Expense Growth
22.76%
Quarterly · Period ending:
TVRD SG&A Expense Growth
Latest reported22.76%period ending
Latest reported22.76%period ending
TVRD Quarterly SG&A Growth (QoQ) (0.00% → 22.76%)
Latest values, visible window
High-resolution chart · PNG
TVRD sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 22.757% | |
| 2.0992% | |
| -10.2355% | |
| -23.7675% | |
| -33.9301% | |
| 110.8231% | |
| 149.6027% | |
| 36.5891% | |
| -90.4951% | |
| 3.6189% | |
| -2.6026% | |
| 0% |